BBR can downregulate hepatic expression of uncoupling protein-2 (UCP2) mRNA protein in NAFLD rats, promote the recovery of hepatocyte steatosis, and improve lipid metabolism disorder [58]. The gene discussed is UCP2; the disease is metabolic dysfunction-associated steatotic liver disease.